Recent News

• 03.18.2025 - CARGO Therapeutics Provides Corporate Update
• 01.29.2025 - CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
• 01.13.2025 - J.P. Morgan 43rd Annual Healthcare Conference
• 01.10.2025 - CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025
• 12.17.2024 - CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
• 12.07.2024 - CRG-023 Presentation
• 12.04.2024 - Piper Sandler 36th Annual Healthcare Conference

Recent Filings

• 03.12.2025 - POS AM Post-Effective amendments for registration statement
• 03.12.2025 - POS AM Post-Effective amendments for registration statement
• 03.12.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.12.2025 - POSASR Post-effective Amendment to an automatic shelf registration statement
• 03.12.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.24.2025 - 8-K Current report
• 02.24.2025 - EX-99.1 EX-99.1
• 02.21.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.29.2025 - 8-K Current report